Denmark offers a solid and reliable entry-point into the European medical cannabis market. In January 2018, the Danish government implemented a four-year medical cannabis pilot programme along with a special development scheme that provides licenses to grow and handle cannabis to develop medical cannabis based products. In November 2018, the government passed a subsequent motion to allow bulk exports of medical cannabis.

The medical cannabis market has developed rapidly since 2018. The dominos are falling and several countries across Europe and the world are adopting medical cannabis programs. Denmark is on track to be one of the world’s largest GACP cultivation nations with more than 3 million SQF of cultivation on its way to be built out. The Open Access Government January 2020 publication has just landed wherein our Special Advisor, Derek Light and Investment Manager, Michael Prytz talk about the medical cannabis market in Denmark and Europe.

Read the full article here

Several of the largest companies in the industry have already set up in Denmark, based on strong but transparent regulations, availability of expertise and experience from both the pharma and horticulture sectors, strong commitment to innovation, sustainability, and cutting edge automated production methods, and opportunities for growth in the Danish and European markets.